Testing effectiveness (Phase 2)UnknownNCT03833440
What this trial is testing
Precision Immuno-Oncology for Advanced Non-small Cell Lung Cancer Patients With PD-1 ICI Resistance
Who this might be right for
Non-small Cell Lung Cancer
Assistance Publique Hopitaux De Marseille 114